Early-Stage Investigators Research on on SLC13A5 Citrate Transporter Disorder

TESS Research Foundation’s mission is to improve the lives of those affected by SLC13A5 Citrate Transporter Disorder (SLC13A5 Epilepsy) through research and community.

This research grant award is intended to provide funding for an early-stage investigator (within 5 years of terminal degree).

Funding: $25,000 

Duration: 1 year

Research Authority due date: 30.1.22